Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pramipexole
Drug ID BADD_D01817
Description Pramipexole is a drug used to treat the symptoms of Parkinson's Disease (PD). It is a _non-ergot dopamine agonist_ drug that is efficacious in treating various Parkinson's symptoms such as tremor, rigidity, and bradykinesia (slow movement) [A176867]. It was first approved by the FDA in 1997 [L5882]. Parkinson's Disease is one of the most common neurodegenerative disorders and causes a high level of disability in patients [A176855], leading to increased difficulty in performing activities of daily living due to symptoms that progress over time [A176858]. The prevalence of Parkinson's Disease worldwide has increased from approximately 2.5 million in 1990 to about 6.1 million in 2016 [A176861]. This increase may be attributed to an aging population along with other contributing factors [A176861]. In addition to the above FDA approval for Parkinson's Disease, pramipexole was also approved by the FDA in 2006 for the treatment of Restless Legs Syndrome (RLS) [A176873]. RLS is a sleep-related disorder characterized by unpleasant sensations in the lower extremities, often accompanied by an uncontrollable urge to move the legs [A176876].
Indications and Usage For the treatment of signs and symptoms of idiopathic Parkinson's disease
Marketing Status Prescription; Discontinued
ATC Code N04BC05
DrugBank ID DB00413
KEGG ID D05575
MeSH ID D000077487
PubChem ID 119570
TTD Drug ID D0G8NN
NDC Product Code 10370-253; 31722-908; 10370-306; 31722-906; 31722-910; 31722-911; 10370-251; 10370-252; 31722-909; 10370-305; 31722-907; 10370-254
Synonyms Pramipexole | 4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine | Pramipexol | 2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole | Dexpramipexole | Pramipexol, (R)-isomer | Mirapex | Pramipexol Dihydrobromide, (+-)-isomer | Pramipexol Dihydrochloride, (S)-isomer | Pramipexole Dihydrochloride Anhydrous | Sifrol | SND 919CL2x | SND919CL2x | SND-919CL2x | SND-919 | SND 919 | KNS 760704 | KNS760704 | KNS-760704 | Pramipexol, (+-)-isomer | Pramipexole Dihydrochloride | Pramipexole Hydrochloride Monohydrate | 2-Amino-6-propylaminotetrahydrobenzothiazole | 2 Amino 6 propylaminotetrahydrobenzothiazole | 6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate
Chemical Information
Molecular Formula C10H17N3S
CAS Registry Number 104632-26-0
SMILES CCCNC1CCC2=C(C1)SC(=N2)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Bulimia nervosaD(3) dopamine receptorP19020Not Available25610366
Early satietyD(3) dopamine receptorP19020Not Available25610366
Food cravingD(3) dopamine receptorP19020Not Available25610366
Impulse control disordersD(3) dopamine receptorP19020Not Available25610366
Impulse-control disorderD(3) dopamine receptorP19020Not Available25610366
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Compulsive shopping19.06.05.0040.004378%Not Available
Acute kidney injury20.01.03.016--
Upper-airway cough syndrome22.02.05.030--
Drug-induced liver injury12.03.01.044; 09.01.07.0230.001824%Not Available
Substance-induced psychotic disorder19.03.01.007; 12.03.01.0530.000730%Not Available
Hepatic cancer16.07.02.004; 09.04.02.008--Not Available
Anal incontinence17.05.01.021; 07.01.06.029--
Frustration tolerance decreased19.04.02.0160.001459%Not Available
Gambling disorder19.07.02.0140.013500%Not Available
Alcohol interaction08.06.03.0030.000730%Not Available
Concomitant disease aggravated08.01.03.0630.000286%Not Available
Eosinophilic fasciitis15.06.01.013; 10.04.02.008; 01.02.04.0100.001459%Not Available
Impulsive behaviour19.18.01.0010.001459%Not Available
Jealous delusion19.10.01.0060.004378%Not Available
Paraphilia19.08.06.0020.000730%Not Available
Social anxiety disorder19.06.03.0100.000730%Not Available
Somatic delusion19.10.01.0080.000730%Not Available
Grip strength decreased13.15.01.0410.001459%Not Available
Dopamine dysregulation syndrome19.07.02.018; 17.01.05.0120.002554%Not Available
Compulsive hoarding19.06.05.0090.001459%Not Available
Penis injury21.12.01.021; 12.01.15.0060.000730%Not Available
Camptocormia17.02.05.053; 15.03.01.0220.000730%Not Available
Executive dysfunction19.21.02.0100.000730%Not Available
Parkinsonism hyperpyrexia syndrome08.06.02.018; 17.01.05.0130.000730%Not Available
Dropped head syndrome15.05.06.002; 17.05.03.0150.000190%Not Available
Postural tremor17.01.06.0090.000730%Not Available
The 22th Page    First    Pre   22    Total 22 Pages